Skip to main content

Arteris Inc

For the period ended Dec 31, 2023. Filed Feb 20, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 20, 2024

AIP$19.09-0.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 15. Exhibits, Financial Statement Schedules

The following documents are filed as part of this Annual Report on Form 10-K:

(a) Consolidated Financial Statements

The consolidated financial statements are filed as part of this Annual Report on Form 10-K under “Item 8. Financial Statements and Supplementary Data.”

(b) Financial Statement Schedules

The financial statement schedules are omitted because they are either not applicable or the information required is presented in the financial statements and notes thereto under “Item 8. Financial Statements and Supplementary Data.”

(c) Exhibits

The following documents are filed, furnished, or incorporated by reference as part of this Annual Report on Form 10-K.

EXHIBIT NO. · DESCRIPTION OF EXHIBIT · Form · Exhibit · Filing Date · FILEDHEREWITH
3.1Amended and Restated Certificate of Incorporation of Arteris, Inc.8-K3.110-29-2021
3.2Amended and Restated Bylaws of Arteris, Inc.8-K3.210-29-2021
4.1Specimen Stock Certificate evidencing the shares of common stock.S-1/A4.110-18-2021
10.1Investors’ Rights Agreement, dated February 5, 2016, by and among Arteris, Inc. and the investors listed therein.S-110.110-01-2021
10.2Amended and Restated Business Financing Agreement, by and between Arteris, Inc. and Western Alliance Bank dated as of December 16, 2020.S-110.210-01-2021
10.3†License Agreement, dated as of October 11, 2013, by and between Arteris, Inc. and Qualcomm Technologies, Inc.S-110.310-01-2021
10.4†Asset Purchase Agreement, dated as of October 9, 2013, by and among Qualcomm Technologies, Inc., Qualcomm France SARL, Arteris Holdings, Inc., Arteris, Inc. and Arteris, SASS-110.410-01-2021
10.5#Employment Agreement, by and between Arteris, Inc. and K. Charles Janac.S-110.610-01-2021
10.6#Employment Agreement, by and between Arteris IP SAS and Isabelle Geday.S-110.110-01-2021
10.7#Arteris, Inc. 2016 Equity Incentive Plan and related form agreements, as amended.S-899.1(a)11-01-2021
10.8#Arteris, Inc. 2016 Equity Incentive Plan for the Grant of Restricted Stock Unit Awards to Employees in France.S-110.1210-01-2021
10.9#2021 Incentive Award Plan.S-899.2(a)11-01-2021
10.10#Form of Stock Option Award Agreement under Arteris, Inc. 2021 Incentive Award Plan.S-1/A10.1410-18-2021
10.11#Form of Restricted Stock Unit Award Agreement under Arteris, Inc. 2021 Incentive Award PlanS-1/A10.1510-18-2021
10.12#2021 Employee Stock Purchase PlanS-899.311-01-2021
10.13#Form of Executive Change in Control Severance AgreementS-1/A10.1710-18-2021
10.14#Arteris, Inc. Non-Employee Director Compensation Policy.S-1/A10.1810-18-2021
10.15#Form of Indemnification Agreement between Arteris, Inc. and its directors and officers.S-1/A10.1910-18-2021
10.16#Amended and Restated Project Assignment 1 to Independent Contractor Services Agreement8-K10.112-10-2021
EXHIBIT NO.DESCRIPTION OF EXHIBITFormExhibitFiling DateFILEDHEREWITH
10.17#Contractor’s Assignment of Independent Contractor Services Agreement as Amended, from Isabelle Geday to Magillem Design Services S.A., effective as of January 10, 202210-K10.2103-07-2022
10.18Transchip Share Purchase and Shareholders Agreement, dated February 21, 202210-Q10.105-10-2022
10.19Transchip Share Purchase and Shareholders Agreement, dated September 15, 202210-Q10.111-08-2022
10.20#2022 Employment Inducement Award Plan10-Q10.211-08-2022
10.21#Form of Stock Option Grant Notice and Stock Option Agreement under the 2022 Employment Inducement Award Plan10-Q10.311-08-2022
10.22#Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2022 Employment Inducement Award Plan10-Q10.411-08-2022
21.1Subsidiaries of Arteris, Inc.X
23.1Consent of Deloitte & Touche LLPX
23.2Consent of Moss Adams LLP.X
24.1Power of Attorney (included on signature page).X
31.1Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
31.2Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
32.1*Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.X
32.2*Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.X
97.1Policy Relating to Recovery of Erroneously Awarded CompensationX
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.X
101.SCHXBRL Taxonomy Extension Schema Document.X
101.CALXBRL Taxonomy Extension Calculation Linkbase Document.X
101.DEFXBRL Taxonomy Extension Definition Linkbase Document.X
101.LABXBRL Taxonomy Extension Label Linkbase Document.X
101.PREXBRL Taxonomy Extension Presentation Linkbase Document.X
104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibits 101).X

*The certifications attached as Exhibits 32.1 and 32.2 that accompany this Annual Report on Form 10-K, are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Arteris, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.